Systematic review / meta-analysis / 2012
Antioxidant supplements did not reduce mortality and in low-bias trials significantly increased mortality, particularly beta-carotene and vitamin E.
Researchers analyzed 78 randomized trials examining oral antioxidant supplements (beta-carotene, vitamin A, vitamin C, vitamin E, selenium) versus placebo or no intervention. Overall, antioxidant supplements had no significant effect on mortality under a random-effects model (RR 1.02, 95% CI 0.98 to 1.05), but significantly increased mortality in a fixed-effect model (RR 1.03, 95% CI 1.01 to 1.05). In 56 trials with low risk of bias, supplements significantly increased mortality (RR 1.04, 95% CI 1.01 to 1.07), driven by beta-carotene (RR 1.05, 95% CI 1.01 to 1.09) and vitamin E (RR 1.03, 95% CI 1.00 to 1.05). Vitamin A, vitamin C, and selenium did not significantly affect mortality, though higher vitamin A doses were linked to increased mortality in meta-regression (P = 0.002).
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 296,707 participants across 78 trials (215,900 healthy, 80,807 with various diseases in a stable phase; mean age 63 years, 46% women)
- What was measured
- All-cause mortality
THE PAPER
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Cochrane Database Syst Rev, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.